AEON Biopharma, Inc. (AEON) — Defensive Interval Ratio

Latest as of June 2021: 225 days

AEON Biopharma, Inc. (AEON) has a Defensive Interval Ratio of 225 days as of June 2021. Defensive assets of $5.44 Million (cash $-, short-term investments $-, receivables $5.44 Million) cover 225 days of daily cash needs of $24.22K/day. See how liquid is AEON Biopharma, Inc.'s working capital to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

225 days
Days of operational coverage

Defensive Assets

$5.44 Million
Cash + ST Investments + Receivables

Daily Cash Need

$24.22K
Current Liabilities ÷ 365

Current Liabilities

$8.84 Million
USD

AEON Biopharma, Inc. Defensive Interval Ratio (2019–2020)

This chart shows how AEON Biopharma, Inc.'s Defensive Interval Ratio has evolved across 2 annual periods from 2019 to 2020. As of June 2021, the ratio stands at 225 days, meaning defensive assets of $5.44 Million can fund 225 days of operations without new revenue. Also explore AEON Biopharma, Inc. equity growth rate to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for AEON Biopharma, Inc. (2019–2020)

The table below presents the year-by-year Defensive Interval Ratio for AEON Biopharma, Inc. from 2019 to 2020, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see AEON company net worth.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2020 0 days $0.00 $11.50K/day $- $0.00 ▼ -2205 days
2019 2205 days $105.69 Million $47.93K/day $- $105.42 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)